Psychopharmacology of Autism Spectrum Disorders

ArticleinPediatric Clinics of North America 59(1):175-87, xii · February 2012with7 Reads
Impact Factor: 2.12 · DOI: 10.1016/j.pcl.2011.10.005 · Source: PubMed

    Abstract

    At present, no evidence-based effective pharmacologic options are available for treating the core deficits of autism spectrum disorders (ASDs), which are best addressed by behavioral and educational interventions. However, such evidence exists for several of the frequently associated/comorbid symptoms such as aggression and severe irritability, hyperactivity, and repetitive behaviors, which can become a major source of additional distress and interference in functioning. This article offers information on the psychopharmacology of ASD that is current, relevant, and organized in a user-friendly manner, to form a concise but informative reference guide for primary pediatric clinicians.